Canada markets closed

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.7000+0.7700 (+19.59%)
At close: 04:00PM EDT
4.6500 -0.05 (-1.06%)
After hours: 07:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
705
1,809
860
Operating Expenses
Research Development
59,471
59,471
51,999
85,352
53,274
Selling General and Administrative
30,300
30,300
26,700
23,600
19,200
Total Operating Expenses
88,770
88,770
64,283
87,984
53,162
Operating Income or Loss
-88,770
-88,770
-63,578
-86,175
-52,302
Interest Expense
16,461
16,461
4,401
242
255
Total Other Income/Expenses Net
-520,135
-520,135
-12,273
-2,174
-325
Income Before Tax
-614,928
-614,928
-78,782
-88,602
-52,910
Income Tax Expense
-
-
-
0
-213
Income from Continuing Operations
-614,928
-614,928
-78,782
-88,602
-52,697
Net Income
-614,928
-614,928
-78,782
-88,602
-52,697
Net Income available to common shareholders
-614,928
-614,928
-78,782
-88,602
-52,697
Basic EPS
-1.02
-0.99
-0.41
-0.67
-0.76
Diluted EPS
-1.02
-0.99
-0.41
-0.67
-0.76
Basic Average Shares
516,226
619,646
193,336
131,714
69,524
Diluted Average Shares
516,226
619,646
193,336
131,714
69,524